RadNet Inc

Post-Capitulation exhaustion at the flush low has established a mean-reversion foundation. Small overlapping candles with long lower wicks hold above the April lows, and RSI remains flat near oversold. Price is pulling back into declining 9/21/50 EMAs without clear acceptance or rejection. Medium-term bias is bullish under mean-reversion permission, but short-term timing is neutral; we will stalk deferred buy into the EMA support zone pending a clean resolution.

• ↑Q1 2026 revenue $230M (+22.1% YoY) and adjusted EBITDA $57M (+36.3%).
• ↑Advanced imaging now represents 29.3% of procedure volume, boosting margins.
• ↓Anticipates $30M same-center labor cost increases in 2026, squeezing margins.